Brief: Virpax Pharmaceuticals Enters Into CRADA With The National Advisory Neurological Disorders And Stroke Council
21/06/2023 13:09
June 21 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS ENTERS INTO CRADA WITH THE NATIONAL
ADVISORY NEUROLOGICAL DISORDERS AND STROKE COUNCIL
Source text for Eikon: ID:nBw1MdghCa
Further company coverage: VRPX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study